$BCBP
BCB BANCORP INC

2020 Q4 Form 10-Q Financial Statement

#000122845420000012 Filed on November 04, 2020

View on sec.gov

Income Statement

Concept 2020 Q4 2020 Q3 2019 Q3
Revenue $28.34M $28.47M $31.37M
YoY Change -8.5% -9.24% 12.13%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $800.0K $700.0K $700.0K
YoY Change 0.0% 0.0% 0.0%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense $5.584M $7.576M $10.61M
YoY Change -48.72% -28.56% 34.39%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $10.20M $11.78M $7.591M
YoY Change 39.52% 55.14% 14.43%
Income Tax $2.904M $3.465M $2.359M
% Of Pretax Income 28.47% 29.42% 31.08%
Net Earnings $7.298M $8.312M $5.232M
YoY Change 42.43% 58.87% 13.89%
Net Earnings / Revenue 25.76% 29.2% 16.68%
Basic Earnings Per Share $0.41 $0.47 $0.30
Diluted Earnings Per Share $0.41 $0.47 $0.30
COMMON SHARES
Basic Shares Outstanding 17.08M 17.07M 16.47M
Diluted Shares Outstanding 17.07M 16.52M

Balance Sheet

Concept 2020 Q4 2020 Q3 2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $261.2M $160.6M $376.6M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $15.27M $15.97M $20.32M
YoY Change -23.33% -21.4% -0.38%
Goodwill $5.200M $5.300M
YoY Change -1.89% 1.92%
Intangibles
YoY Change
Long-Term Investments $17.72M $14.50M $5.857M
YoY Change 608.68% 147.58% -27.26%
Other Assets $12.60M $12.20M $13.40M
YoY Change 12.5% -8.96% 15.52%
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $2.821B $2.842B $2.825B
YoY Change -2.97% 0.6% 7.11%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $15.20M $16.00M $14.10M
YoY Change -43.28% 13.48%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $15.20M $16.00M $14.10M
YoY Change -43.28% 13.48%
LONG-TERM LIABILITIES
Long-Term Debt $37.00M $37.00M $36.80M
YoY Change 0.54% 0.54% 0.82%
Other Long-Term Liabilities $10.30M $13.70M $11.70M
YoY Change -402.94% 17.09% -11.36%
Total Long-Term Liabilities $47.30M $50.70M $48.50M
YoY Change 41.62% 4.54% -2.41%
TOTAL LIABILITIES
Total Short-Term Liabilities $15.20M $16.00M $14.10M
Total Long-Term Liabilities $47.30M $50.70M $48.50M
Total Liabilities $2.572B $2.600B $2.602B
YoY Change -3.61% -0.08% 6.54%
SHAREHOLDERS EQUITY
Retained Earnings $58.34M $53.74M $45.95M
YoY Change 20.45% 16.97% 28.73%
Common Stock $192.3M $191.8M $177.3M
YoY Change 1.04% 8.18% 0.73%
Preferred Stock $25.72M $23.48M $25.02M
YoY Change 2.83% -6.14% 26.95%
Treasury Stock (at cost) $26.92M $26.92M $22.05M
YoY Change 22.09% 22.09% -24.28%
Treasury Stock Shares $2.467M $2.467M $1.967M
Shareholders Equity $249.2M $242.7M $223.7M
YoY Change
Total Liabilities & Shareholders Equity $2.821B $2.842B $2.825B
YoY Change -2.97% 0.6% 7.11%

Cashflow Statement

Concept 2020 Q4 2020 Q3 2019 Q3
OPERATING ACTIVITIES
Net Income $7.298M $8.312M $5.232M
YoY Change 42.43% 58.87% 13.89%
Depreciation, Depletion And Amortization $800.0K $700.0K $700.0K
YoY Change 0.0% 0.0% 0.0%
Cash From Operating Activities $132.7M $4.000M $4.200M
YoY Change 1326.88% -4.76% -14.29%
INVESTING ACTIVITIES
Capital Expenditures -$100.0K -$1.100M -$1.600M
YoY Change -66.67% -31.25% 1500.0%
Acquisitions
YoY Change
Other Investing Activities -$8.100M -$95.50M $63.50M
YoY Change -109.41% -250.39% -166.08%
Cash From Investing Activities -$8.200M -$96.60M $62.00M
YoY Change -109.57% -255.81% -164.38%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -23.90M -159.1M 82.80M
YoY Change -130.37% -292.15% -29.59%
NET CHANGE
Cash From Operating Activities 132.7M 4.000M 4.200M
Cash From Investing Activities -8.200M -96.60M 62.00M
Cash From Financing Activities -23.90M -159.1M 82.80M
Net Change In Cash 100.6M -251.7M 149.0M
YoY Change -42.08% -268.93% 468.7%
FREE CASH FLOW
Cash From Operating Activities $132.7M $4.000M $4.200M
Capital Expenditures -$100.0K -$1.100M -$1.600M
Free Cash Flow $132.8M $5.100M $5.800M
YoY Change 1283.33% -12.07% 16.0%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001228454
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
CY2020Q3 us-gaap Common Stock Value
CommonStockValue
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q3 us-gaap Preferred Stock Value
PreferredStockValue
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
CY2020Q3 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2020-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
0-50275
dei Entity Registrant Name
EntityRegistrantName
BCB Bancorp, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NJ
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-0065262
dei Entity Address Address Line1
EntityAddressAddressLine1
104-110 Avenue C
dei Entity Address City Or Town
EntityAddressCityOrTown
Bayonne
dei Entity Address State Or Province
EntityAddressStateOrProvince
NJ
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
07002
dei City Area Code
CityAreaCode
201
dei Local Phone Number
LocalPhoneNumber
823-0700
dei Security12b Title
Security12bTitle
Common Stock, no par value
dei Trading Symbol
TradingSymbol
BCBP
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2020Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
17081191
CY2020Q3 us-gaap Cash And Due From Banks
CashAndDueFromBanks
18938000
CY2019Q4 us-gaap Cash And Due From Banks
CashAndDueFromBanks
24985000
CY2020Q3 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
141613000
CY2019Q4 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
525368000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
160551000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
550353000
CY2020Q3 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
735000
CY2019Q4 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
735000
CY2020Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
119643000
CY2019Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
91613000
CY2020Q3 us-gaap Equity Method Investments
EquityMethodInvestments
14501000
CY2019Q4 us-gaap Equity Method Investments
EquityMethodInvestments
2500000
CY2020Q3 us-gaap Loans Receivable Held For Sale Net Not Part Of Disposal Group
LoansReceivableHeldForSaleNetNotPartOfDisposalGroup
1510000
CY2019Q4 us-gaap Loans Receivable Held For Sale Net Not Part Of Disposal Group
LoansReceivableHeldForSaleNetNotPartOfDisposalGroup
917000
CY2020Q3 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
31760000
CY2019Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
23734000
CY2020Q3 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
2391990000
CY2019Q4 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
2178407000
CY2020Q3 us-gaap Federal Home Loan Bank Stock
FederalHomeLoanBankStock
13160000
CY2019Q4 us-gaap Federal Home Loan Bank Stock
FederalHomeLoanBankStock
13821000
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
15968000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
19920000
CY2020Q3 us-gaap Interest Receivable
InterestReceivable
17746000
CY2019Q4 us-gaap Interest Receivable
InterestReceivable
8318000
CY2020Q3 us-gaap Other Real Estate
OtherRealEstate
1623000
CY2019Q4 us-gaap Other Real Estate
OtherRealEstate
1623000
CY2020Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
12184000
CY2019Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
11180000
CY2020Q3 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
5503000
CY2019Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
5552000
CY2020Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
15798000
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
13246000
CY2020Q3 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
60385000
CY2020Q3 us-gaap Other Assets
OtherAssets
11022000
CY2019Q4 us-gaap Other Assets
OtherAssets
9283000
CY2020Q3 us-gaap Assets
Assets
2842319000
CY2019Q4 us-gaap Assets
Assets
2907468000
CY2020Q3 us-gaap Noninterest Bearing Deposit Liabilities Domestic
NoninterestBearingDepositLiabilitiesDomestic
395630000
CY2019Q4 us-gaap Noninterest Bearing Deposit Liabilities Domestic
NoninterestBearingDepositLiabilitiesDomestic
271702000
CY2020Q3 us-gaap Interest Bearing Deposit Liabilities Domestic
InterestBearingDepositLiabilitiesDomestic
1877708000
CY2019Q4 us-gaap Interest Bearing Deposit Liabilities Domestic
InterestBearingDepositLiabilitiesDomestic
2090361000
CY2020Q3 us-gaap Deposits
Deposits
2273338000
CY2019Q4 us-gaap Deposits
Deposits
2362063000
CY2020Q3 us-gaap Federal Home Loan Bank Advances Branch Of Fhlb Bank Amount Of Advances By Branch
FederalHomeLoanBankAdvancesBranchOfFHLBBankAmountOfAdvancesByBranch
259600000
CY2019Q4 us-gaap Federal Home Loan Bank Advances Branch Of Fhlb Bank Amount Of Advances By Branch
FederalHomeLoanBankAdvancesBranchOfFHLBBankAmountOfAdvancesByBranch
245800000
CY2020Q3 us-gaap Subordinated Debt
SubordinatedDebt
36984000
CY2019Q4 us-gaap Subordinated Debt
SubordinatedDebt
36810000
CY2020Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
16004000
CY2019Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
13380000
CY2020Q3 us-gaap Other Liabilities
OtherLiabilities
13706000
CY2019Q4 us-gaap Other Liabilities
OtherLiabilities
9942000
CY2020Q3 us-gaap Liabilities
Liabilities
2599632000
CY2019Q4 us-gaap Liabilities
Liabilities
2667995000
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2020Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2020Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
2371
CY2020Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
2371
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
8340
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
8340
CY2020Q3 us-gaap Additional Paid In Capital Preferred Stock
AdditionalPaidInCapitalPreferredStock
23481000
CY2019Q4 us-gaap Additional Paid In Capital Preferred Stock
AdditionalPaidInCapitalPreferredStock
25016000
CY2019Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2020Q3 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19548409
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19484046
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
17081191
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
17516828
CY2020Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
191755000
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
190294000
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
53742000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
48429000
CY2020Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
627000
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2218000
CY2020Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
2467218
CY2019Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
1967218
CY2020Q3 us-gaap Treasury Stock Value
TreasuryStockValue
26918000
CY2019Q4 us-gaap Treasury Stock Value
TreasuryStockValue
22048000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
242687000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
239473000
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2842319000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2907468000
CY2020Q3 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
27126000
CY2019Q3 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
28860000
us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
80063000
us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
85727000
CY2020Q3 us-gaap Interest Income Securities Mortgage Backed
InterestIncomeSecuritiesMortgageBacked
393000
CY2019Q3 us-gaap Interest Income Securities Mortgage Backed
InterestIncomeSecuritiesMortgageBacked
652000
us-gaap Interest Income Securities Mortgage Backed
InterestIncomeSecuritiesMortgageBacked
1450000
us-gaap Interest Income Securities Mortgage Backed
InterestIncomeSecuritiesMortgageBacked
2160000
CY2020Q3 us-gaap Interest Income Other
InterestIncomeOther
693000
CY2019Q3 us-gaap Interest Income Other
InterestIncomeOther
107000
us-gaap Interest Income Other
InterestIncomeOther
947000
us-gaap Interest Income Other
InterestIncomeOther
432000
CY2020Q3 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
254000
CY2019Q3 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
1750000
us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
2631000
us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
4270000
CY2020Q3 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
28466000
CY2019Q3 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
31369000
us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
85091000
us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
92589000
CY2020Q3 us-gaap Interest Expense Demand Deposit Accounts
InterestExpenseDemandDepositAccounts
1157000
CY2019Q3 us-gaap Interest Expense Demand Deposit Accounts
InterestExpenseDemandDepositAccounts
1898000
us-gaap Interest Expense Demand Deposit Accounts
InterestExpenseDemandDepositAccounts
4927000
us-gaap Interest Expense Demand Deposit Accounts
InterestExpenseDemandDepositAccounts
5224000
CY2020Q3 us-gaap Interest Expense Savings Deposits
InterestExpenseSavingsDeposits
113000
CY2019Q3 us-gaap Interest Expense Savings Deposits
InterestExpenseSavingsDeposits
102000
us-gaap Interest Expense Savings Deposits
InterestExpenseSavingsDeposits
324000
us-gaap Interest Expense Savings Deposits
InterestExpenseSavingsDeposits
325000
CY2020Q3 us-gaap Interest Expense Time Deposits
InterestExpenseTimeDeposits
4531000
CY2019Q3 us-gaap Interest Expense Time Deposits
InterestExpenseTimeDeposits
6603000
us-gaap Interest Expense Time Deposits
InterestExpenseTimeDeposits
16658000
us-gaap Interest Expense Time Deposits
InterestExpenseTimeDeposits
18690000
CY2020Q3 us-gaap Interest Expense Deposits
InterestExpenseDeposits
5801000
CY2019Q3 us-gaap Interest Expense Deposits
InterestExpenseDeposits
8603000
us-gaap Interest Expense Deposits
InterestExpenseDeposits
21909000
us-gaap Interest Expense Deposits
InterestExpenseDeposits
24239000
CY2020Q3 us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
1775000
CY2019Q3 us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
2006000
us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
5523000
us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
5823000
CY2020Q3 us-gaap Interest Expense
InterestExpense
7576000
CY2019Q3 us-gaap Interest Expense
InterestExpense
10609000
us-gaap Interest Expense
InterestExpense
27432000
us-gaap Interest Expense
InterestExpense
30062000
CY2020Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
20890000
CY2019Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
20760000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
57659000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
62527000
CY2020Q3 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
2726000
CY2019Q3 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
900000
us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
7526000
us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
2544000
CY2020Q3 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
18164000
CY2019Q3 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
19860000
us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
50133000
CY2020Q3 us-gaap Professional Fees
ProfessionalFees
421000
CY2019Q3 us-gaap Professional Fees
ProfessionalFees
368000
us-gaap Professional Fees
ProfessionalFees
1289000
us-gaap Professional Fees
ProfessionalFees
1474000
us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
59983000
CY2020Q3 us-gaap Underwriting Income Loss
UnderwritingIncomeLoss
875000
CY2019Q3 us-gaap Underwriting Income Loss
UnderwritingIncomeLoss
855000
us-gaap Underwriting Income Loss
UnderwritingIncomeLoss
2138000
us-gaap Underwriting Income Loss
UnderwritingIncomeLoss
2540000
CY2020Q3 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
174000
CY2019Q3 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
89000
us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
292000
us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
844000
bcbp Gain Loss On Bulk Sale Of Impaired Loans Held In Portfolio
GainLossOnBulkSaleOfImpairedLoansHeldInPortfolio
107000
CY2019Q3 us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
124000
us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
177000
CY2020Q3 us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
306000
CY2019Q3 us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
283000
us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
306000
us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
304000
CY2020Q3 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
4378000
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
4378000
CY2020Q3 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
385000
us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
385000
CY2020Q3 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
778000
CY2019Q3 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-45000
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
820000
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
220000
CY2020Q3 us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
59000
CY2019Q3 us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
77000
us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
427000
us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
179000
CY2020Q3 us-gaap Noninterest Income
NoninterestIncome
6955000
CY2019Q3 us-gaap Noninterest Income
NoninterestIncome
1383000
us-gaap Noninterest Income
NoninterestIncome
8746000
us-gaap Noninterest Income
NoninterestIncome
4371000
CY2020Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
6385000
CY2019Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
7294000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
19456000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
21127000
CY2020Q3 us-gaap Occupancy Net
OccupancyNet
2996000
CY2019Q3 us-gaap Occupancy Net
OccupancyNet
2647000
us-gaap Occupancy Net
OccupancyNet
8730000
us-gaap Occupancy Net
OccupancyNet
7926000
CY2020Q3 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
937000
CY2019Q3 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
776000
us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
2826000
us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
2128000
CY2020Q3 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
471000
CY2019Q3 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
356000
us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
1194000
us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
990000
CY2020Q3 bcbp Regulatory Assessments
RegulatoryAssessments
311000
CY2019Q3 bcbp Regulatory Assessments
RegulatoryAssessments
-91000
bcbp Regulatory Assessments
RegulatoryAssessments
883000
bcbp Regulatory Assessments
RegulatoryAssessments
783000
CY2020Q3 us-gaap Advertising Expense
AdvertisingExpense
18000
CY2019Q3 us-gaap Advertising Expense
AdvertisingExpense
64000
us-gaap Advertising Expense
AdvertisingExpense
105000
us-gaap Advertising Expense
AdvertisingExpense
260000
CY2020Q3 us-gaap Foreclosed Real Estate Expense
ForeclosedRealEstateExpense
11000
CY2019Q3 us-gaap Foreclosed Real Estate Expense
ForeclosedRealEstateExpense
-31000
us-gaap Foreclosed Real Estate Expense
ForeclosedRealEstateExpense
58000
us-gaap Foreclosed Real Estate Expense
ForeclosedRealEstateExpense
77000
CY2020Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-313000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-313000
CY2020Q3 us-gaap Other Noninterest Expense
OtherNoninterestExpense
1479000
CY2019Q3 us-gaap Other Noninterest Expense
OtherNoninterestExpense
2269000
us-gaap Other Noninterest Expense
OtherNoninterestExpense
4804000
us-gaap Other Noninterest Expense
OtherNoninterestExpense
6558000
CY2020Q3 us-gaap Noninterest Expense
NoninterestExpense
13342000
CY2019Q3 us-gaap Noninterest Expense
NoninterestExpense
13652000
us-gaap Noninterest Expense
NoninterestExpense
39658000
us-gaap Noninterest Expense
NoninterestExpense
41323000
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
11777000
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
7591000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
19221000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
23031000
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3465000
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2359000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5662000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7121000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
8312000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
5232000
us-gaap Net Income Loss
NetIncomeLoss
13559000
us-gaap Net Income Loss
NetIncomeLoss
15910000
CY2020Q3 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
332000
CY2019Q3 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
342000
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
1014000
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
1002000
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
7980000
CY2019Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
4890000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
12545000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
14908000
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.47
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.30
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.73
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.91
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.47
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.30
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.73
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.91
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17069000
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16468000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17250000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16320000
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17069000
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16523000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17268000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16369000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
8312000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
5232000
us-gaap Net Income Loss
NetIncomeLoss
13559000
us-gaap Net Income Loss
NetIncomeLoss
15910000
CY2020Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-129000
CY2019Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-713000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
3783000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
3488000
CY2020Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-32000
CY2019Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-193000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
938000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
861000
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-97000
CY2019Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-520000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
2845000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
2627000
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
8215000
CY2019Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
4712000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
16404000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
18537000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
239473000
us-gaap Net Income Loss
NetIncomeLoss
13559000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
2845000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
8950000
us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
10485000
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
500
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
5000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
944000
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
500000
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
4870000
us-gaap Dividends Preferred Stock
DividendsPreferredStock
1014000
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.14
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
6915000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
321000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
242687000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
241019000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
8312000
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-97000
CY2020Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
5870000
CY2020Q3 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
10345000
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
385000
CY2020Q3 us-gaap Dividends Preferred Stock
DividendsPreferredStock
332000
CY2020Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.14
CY2020Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
2227000
CY2020Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
102000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
242687000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
200215000
us-gaap Net Income Loss
NetIncomeLoss
15910000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
2627000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
688000
us-gaap Dividends Preferred Stock
DividendsPreferredStock
1002000
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.14
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
6516000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
248000
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
223719000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
221153000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
5232000
CY2019Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-520000
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
291000
CY2019Q3 us-gaap Dividends Preferred Stock
DividendsPreferredStock
343000
CY2019Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.14
CY2019Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
2190000
CY2019Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
96000
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
223719000
us-gaap Net Income Loss
NetIncomeLoss
13559000
us-gaap Net Income Loss
NetIncomeLoss
15910000
us-gaap Depreciation Nonproduction
DepreciationNonproduction
2216000
us-gaap Depreciation Nonproduction
DepreciationNonproduction
2146000
bcbp Amortization And Accretion Net
AmortizationAndAccretionNet
1864000
bcbp Amortization And Accretion Net
AmortizationAndAccretionNet
2206000
us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
7526000
us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
2544000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1942000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-859000
us-gaap Payments For Origination Of Mortgage Loans Held For Sale
PaymentsForOriginationOfMortgageLoansHeldForSale
13112000
us-gaap Payments For Origination Of Mortgage Loans Held For Sale
PaymentsForOriginationOfMortgageLoansHeldForSale
15065000
us-gaap Proceeds From Sale Of Mortgage Loans Held For Sale
ProceedsFromSaleOfMortgageLoansHeldForSale
12811000
us-gaap Proceeds From Sale Of Mortgage Loans Held For Sale
ProceedsFromSaleOfMortgageLoansHeldForSale
13867000
us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
292000
us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
844000
us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
177000
us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
306000
us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
304000
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
4378000
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
820000
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
220000
bcbp Gain Loss On Bulk Sale Of Impaired Loans Held In Portfolio
GainLossOnBulkSaleOfImpairedLoansHeldInPortfolio
107000
us-gaap Share Based Compensation
ShareBasedCompensation
944000
us-gaap Share Based Compensation
ShareBasedCompensation
688000
us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
385000
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
9428000
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
581000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1739000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
307000
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-1223000
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-331000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
4987000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
831000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
6554000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
14985000
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
24663000
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
13691000
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
70561000
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
1153000
us-gaap Proceeds From Sale Of Foreclosed Assets
ProceedsFromSaleOfForeclosedAssets
2417000
bcbp Proceeds From Sale Of Impaired Loans
ProceedsFromSaleOfImpairedLoans
402000
us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
10419000
us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
14234000
us-gaap Payments To Acquire Loans Held For Investment
PaymentsToAcquireLoansHeldForInvestment
48360000
us-gaap Payments For Proceeds From Loans Receivable
PaymentsForProceedsFromLoansReceivable
170233000
us-gaap Payments For Proceeds From Loans Receivable
PaymentsForProceedsFromLoansReceivable
-23693000
us-gaap Proceeds From Federal Home Loan Bank Borrowings
ProceedsFromFederalHomeLoanBankBorrowings
40000000
us-gaap Repayments Of Federal Home Loan Bank Borrowings
RepaymentsOfFederalHomeLoanBankBorrowings
35000000
us-gaap Payments To Acquire Life Insurance Policies
PaymentsToAcquireLifeInsurancePolicies
60000000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1305000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2168000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
7419000
us-gaap Payments For Proceeds From Federal Home Loan Bank Stock
PaymentsForProceedsFromFederalHomeLoanBankStock
-661000
us-gaap Payments For Proceeds From Federal Home Loan Bank Stock
PaymentsForProceedsFromFederalHomeLoanBankStock
1766000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-307297000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
49350000
us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
-88725000
us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
82733000
us-gaap Proceeds From Federal Home Loan Bank Borrowings
ProceedsFromFederalHomeLoanBankBorrowings
48800000
us-gaap Repayments Of Federal Home Loan Bank Borrowings
RepaymentsOfFederalHomeLoanBankBorrowings
10000000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
4870000
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
6915000
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
6516000
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
1014000
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
1002000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
195000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
6487000
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
8950000
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
5310000
us-gaap Payments For Repurchase Of Redeemable Preferred Stock
PaymentsForRepurchaseOfRedeemablePreferredStock
10485000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
5000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-89059000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
117012000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-389802000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
181347000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
550353000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
195264000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
160551000
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
376611000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
10554000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
8492000
us-gaap Interest Paid Net
InterestPaidNet
28656000
us-gaap Interest Paid Net
InterestPaidNet
30393000
us-gaap Transfer To Other Real Estate
TransferToOtherRealEstate
907000
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
us-gaap Reclassifications
Reclassifications
<span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Note 3 – Reclassification </span><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Certain amounts as of December 31, 2019 and for the three-month and nine-month periods September 30, 2019 have been reclassified to conform to the current period’s presentation. These changes had no effect on the Company’s results of operations or financial position.</span></p><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span>
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
81278
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
11.96
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
25232
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
12.40
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
2332
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
11.97
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
53714
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
11.78
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
67321
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
11.26
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
47618
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
12.46
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
114939
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
11.86
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1200975
CY2019 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
8.93
CY2019 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
13.32
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.45
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
500
bcbp Share Based Compensation Shares Authorized Under Stock Option Plan Options Exercised Exercise Price Range
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlanOptionsExercisedExercisePriceRange
10.55
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
10.55
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
8127
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
11.68
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1192348
us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
8.93
us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
13.32
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.45
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
660736
CY2020Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
531612
CY2020Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
1000000.0
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1104600
CY2018 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
8.93
CY2018 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
13.32
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.36
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
98875
bcbp Share Based Compensation Shares Authorized Under Stock Option Plan Options Granted Exercise Price Range
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlanOptionsGrantedExercisePriceRange
12.46
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
12.46
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
1000
bcbp Share Based Compensation Shares Authorized Under Stock Option Plan Options Forfeited Exercise Price Range
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlanOptionsForfeitedExercisePriceRange
10.55
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
10.55
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1202475
us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
8.93
us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
13.32
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.45
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
268633
CY2020Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
CY2019Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
42958
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
32054
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
7980000
CY2019Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
4890000
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
7980000
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17069000
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.47
CY2019Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
4890000
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16468000
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.30
CY2019Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
55000
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
7980000
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17069000
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.47
CY2019Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
4890000
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16523000
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.30
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
12545000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
14908000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
12545000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17250000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.73
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
14908000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16320000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.91
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
18000
CY2019Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
13073000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
49000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
12545000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17268000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.73
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
14908000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16369000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.91
CY2020Q3 us-gaap Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
65000
CY2020Q3 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
10596000
CY2020Q3 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
778000
CY2019Q3 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-45000
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
780000
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
199000
us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
40000
us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
21000
CY2020Q3 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
778000
CY2019Q3 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-45000
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
820000
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
220000
CY2020Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
116514000
CY2020Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
3251000
CY2020Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
122000
CY2020Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
119643000
CY2019Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
3431000
CY2019Q4 bcbp Available For Sale Securities Debt Maturities Year Two Through Year Five Gross Unrealized Gains
AvailableForSaleSecuritiesDebtMaturitiesYearTwoThroughYearFiveGrossUnrealizedGains
8000
CY2019Q4 bcbp Available For Sale Securities Debt Maturities Year Two Through Year Five Gross Unrealized Losses
AvailableForSaleSecuritiesDebtMaturitiesYearTwoThroughYearFiveGrossUnrealizedLosses
72000
CY2019Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
3367000
CY2019Q4 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
1566000
CY2019Q4 bcbp Available For Sale Securities Debt Maturities Year Six Through Ten Gross Unrealized Gains
AvailableForSaleSecuritiesDebtMaturitiesYearSixThroughTenGrossUnrealizedGains
33000
CY2019Q4 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
1599000
CY2019Q4 us-gaap Available For Sale Securities Debt Maturities After Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost
87269000
CY2019Q4 bcbp Available For Sale Securities Debt Maturities After Ten Years Gross Unrealized Gains
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsGrossUnrealizedGains
574000
CY2019Q4 bcbp Available For Sale Securities Debt Maturities After Ten Years Gross Unrealized Losses
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsGrossUnrealizedLosses
1196000
CY2020Q3 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
122000
CY2019Q4 us-gaap Available For Sale Securities Debt Maturities After Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
86647000
CY2019Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
92266000
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
615000
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1268000
CY2019Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
91613000
CY2020Q3 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
8829000
CY2020Q3 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
57000
CY2020Q3 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
1767000
CY2019Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
656000
CY2019Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
23212000
CY2019Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
612000
CY2019Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
36285000
CY2019Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
1268000
CY2020Q3 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
2427180000
CY2019Q4 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
2203315000
CY2020Q3 us-gaap Loans And Leases Receivable Deferred Income
LoansAndLeasesReceivableDeferredIncome
3430000
CY2019Q4 us-gaap Loans And Leases Receivable Deferred Income
LoansAndLeasesReceivableDeferredIncome
1174000
CY2020Q3 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
31760000
CY2019Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
23734000
CY2020Q3 bcbp Total Deductions From Gross Loans
TotalDeductionsFromGrossLoans
35190000
CY2019Q4 bcbp Total Deductions From Gross Loans
TotalDeductionsFromGrossLoans
24908000
CY2020Q3 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
2391990000
CY2019Q4 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
2178407000
CY2020Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
28842000
CY2020Q3 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
2726000
CY2020Q3 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
31760000
CY2020Q3 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
3853000
CY2020Q3 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
27907000
CY2020Q3 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
31760000
CY2020Q3 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
31318000
CY2020Q3 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
2395862000
CY2020Q3 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
2427180000
CY2019Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
23734000
us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
4000
CY2018Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
22359000
us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
257000
us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
45000
us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
2544000
CY2019Q3 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
24691000
us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
504000
us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
7526000
CY2020Q3 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
31760000
CY2019Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
23789000
CY2019Q3 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
1000
CY2019Q3 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
3000
CY2019Q3 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
900000
CY2019Q3 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
24691000
CY2019Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
23734000
CY2019Q4 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
26912000
CY2019Q4 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
2176403000
CY2019Q4 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
2203315000
CY2019Q4 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
3264000
CY2019Q4 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
20470000
CY2019Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
23734000
CY2020Q3 us-gaap Impaired Financing Receivable With No Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment
20880000
CY2020Q3 us-gaap Impaired Financing Receivable With No Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeAccrualMethod
111000
CY2019Q3 us-gaap Impaired Financing Receivable With No Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment
24844000
CY2019Q3 us-gaap Impaired Financing Receivable With No Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeAccrualMethod
239000
us-gaap Impaired Financing Receivable With No Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment
19258000
us-gaap Impaired Financing Receivable With No Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeAccrualMethod
587000
us-gaap Impaired Financing Receivable With No Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment
26919000
us-gaap Impaired Financing Receivable With No Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeAccrualMethod
845000
CY2020Q3 us-gaap Impaired Financing Receivable With Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment
8202000
CY2020Q3 us-gaap Impaired Financing Receivable With Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod
87000
CY2019Q3 us-gaap Impaired Financing Receivable With Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment
9225000
CY2019Q3 us-gaap Impaired Financing Receivable With Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod
74000
us-gaap Impaired Financing Receivable With Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment
7799000
us-gaap Impaired Financing Receivable With Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod
218000
us-gaap Impaired Financing Receivable With Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment
8674000
us-gaap Impaired Financing Receivable With Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod
256000
CY2020Q3 us-gaap Impaired Financing Receivable With No Related Allowance Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment
22903000
CY2020Q3 us-gaap Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance
31217000
CY2019Q4 us-gaap Impaired Financing Receivable With No Related Allowance Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment
19647000
CY2019Q4 us-gaap Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance
29082000
CY2020Q3 us-gaap Impaired Financing Receivable With Related Allowance Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment
8415000
CY2020Q3 us-gaap Impaired Financing Receivable With Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance
12815000
CY2020Q3 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
3853000
CY2019Q4 us-gaap Impaired Financing Receivable With Related Allowance Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment
7265000
CY2019Q4 us-gaap Impaired Financing Receivable With Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance
10270000
CY2019Q4 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
3264000
CY2020Q3 us-gaap Impaired Financing Receivable With No Related Allowance Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment
22903000
CY2020Q3 us-gaap Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance
31217000
CY2019Q4 us-gaap Impaired Financing Receivable With No Related Allowance Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment
19647000
CY2019Q4 us-gaap Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance
29082000
CY2020Q3 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
31318000
CY2020Q3 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
44032000
CY2020Q3 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
3853000
CY2019Q4 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
26912000
CY2019Q4 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
39352000
CY2019Q4 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
3264000
CY2020Q3 us-gaap Financing Receivable Modifications Recorded Investment
FinancingReceivableModificationsRecordedInvestment
17581000
CY2019Q4 us-gaap Financing Receivable Modifications Recorded Investment
FinancingReceivableModificationsRecordedInvestment
17732000
CY2020Q3 us-gaap Financing Receivable Modifications Number Of Contracts2
FinancingReceivableModificationsNumberOfContracts2
5
CY2020Q3 us-gaap Financing Receivable Modifications Post Modification Recorded Investment2
FinancingReceivableModificationsPostModificationRecordedInvestment2
458181
CY2019Q3 us-gaap Financing Receivable Modifications Number Of Contracts2
FinancingReceivableModificationsNumberOfContracts2
3
CY2019Q3 us-gaap Financing Receivable Modifications Post Modification Recorded Investment2
FinancingReceivableModificationsPostModificationRecordedInvestment2
415652
us-gaap Financing Receivable Modifications Number Of Contracts2
FinancingReceivableModificationsNumberOfContracts2
6
us-gaap Financing Receivable Modifications Post Modification Recorded Investment2
FinancingReceivableModificationsPostModificationRecordedInvestment2
674283
us-gaap Financing Receivable Modifications Number Of Contracts2
FinancingReceivableModificationsNumberOfContracts2
6
us-gaap Financing Receivable Modifications Post Modification Recorded Investment2
FinancingReceivableModificationsPostModificationRecordedInvestment2
1800000
CY2020Q3 us-gaap Financing Receivable Modifications Subsequent Default Recorded Investment1
FinancingReceivableModificationsSubsequentDefaultRecordedInvestment1
602274
CY2020Q3 us-gaap Financing Receivable Modifications Subsequent Default Number Of Contracts1
FinancingReceivableModificationsSubsequentDefaultNumberOfContracts1
2
CY2019Q3 us-gaap Financing Receivable Modifications Subsequent Default Recorded Investment1
FinancingReceivableModificationsSubsequentDefaultRecordedInvestment1
105000
CY2019Q3 us-gaap Financing Receivable Modifications Subsequent Default Number Of Contracts1
FinancingReceivableModificationsSubsequentDefaultNumberOfContracts1
1
us-gaap Financing Receivable Modifications Subsequent Default Recorded Investment1
FinancingReceivableModificationsSubsequentDefaultRecordedInvestment1
602274
us-gaap Financing Receivable Modifications Subsequent Default Number Of Contracts1
FinancingReceivableModificationsSubsequentDefaultNumberOfContracts1
2
us-gaap Financing Receivable Modifications Subsequent Default Recorded Investment1
FinancingReceivableModificationsSubsequentDefaultRecordedInvestment1
105000
us-gaap Financing Receivable Modifications Subsequent Default Number Of Contracts1
FinancingReceivableModificationsSubsequentDefaultNumberOfContracts1
1
CY2020Q3 us-gaap Financing Receivable Recorded Investment Past Due
FinancingReceivableRecordedInvestmentPastDue
11035000
CY2020Q3 us-gaap Financing Receivable Recorded Investment Current
FinancingReceivableRecordedInvestmentCurrent
2416145000
CY2020Q3 us-gaap Notes Receivable Net
NotesReceivableNet
2427180000
CY2020Q3 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
1724000
CY2020Q3 us-gaap Certain Loans Acquired In Transfer Accounted For As Debt Securities Acquired During Period At Acquisition At Fair Value
CertainLoansAcquiredInTransferAccountedForAsDebtSecuritiesAcquiredDuringPeriodAtAcquisitionAtFairValue
1100000
CY2019Q4 us-gaap Certain Loans Acquired In Transfer Accounted For As Debt Securities Acquired During Period At Acquisition At Fair Value
CertainLoansAcquiredInTransferAccountedForAsDebtSecuritiesAcquiredDuringPeriodAtAcquisitionAtFairValue
3500000
CY2020Q3 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
7151000
CY2019Q4 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
4160000
us-gaap Loans And Leases Receivable Impaired Interest Lost On Nonaccrual Loans
LoansAndLeasesReceivableImpairedInterestLostOnNonaccrualLoans
673000
CY2019 us-gaap Loans And Leases Receivable Impaired Interest Lost On Nonaccrual Loans
LoansAndLeasesReceivableImpairedInterestLostOnNonaccrualLoans
967000
bcbp Nonaccrual Loans Interest Income Cash Basis Method
NonaccrualLoansInterestIncomeCashBasisMethod
520000
bcbp Nonaccrual Loans Interest Income Cash Basis Method
NonaccrualLoansInterestIncomeCashBasisMethod
1100000
CY2020Q3 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
1700000
CY2019Q4 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
795000
CY2019Q4 us-gaap Financing Receivable Recorded Investment Past Due
FinancingReceivableRecordedInvestmentPastDue
14522000
CY2019Q4 us-gaap Financing Receivable Recorded Investment Current
FinancingReceivableRecordedInvestmentCurrent
2188793000
CY2019Q4 us-gaap Notes Receivable Net
NotesReceivableNet
2203315000
CY2019Q4 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
795000
CY2020Q3 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
2427180000
CY2019Q4 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
2203315000
CY2020Q3 us-gaap Life Insurance Corporate Or Bank Owned Amount
LifeInsuranceCorporateOrBankOwnedAmount
60000000
CY2020Q3 us-gaap Life Insurance Corporate Or Bank Owned Amount
LifeInsuranceCorporateOrBankOwnedAmount
60400000
CY2020Q3 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
385000
CY2020Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
0
CY2020Q3 us-gaap Goodwill
Goodwill
5200000
CY2019Q3 us-gaap Goodwill
Goodwill
5300000
bcbp Transfers Between Fair Value Hierarchies Assets Liabilities
TransfersBetweenFairValueHierarchiesAssetsLiabilities
0
CY2019Q3 bcbp Transfers Between Fair Value Hierarchies Assets Liabilities
TransfersBetweenFairValueHierarchiesAssetsLiabilities
0
CY2020Q3 us-gaap Other Real Estate
OtherRealEstate
1623000
bcbp Transfers Between Fair Value Hierarchies Assets Liabilities
TransfersBetweenFairValueHierarchiesAssetsLiabilities
0
CY2020Q3 bcbp Transfers Between Fair Value Hierarchies Assets Liabilities
TransfersBetweenFairValueHierarchiesAssetsLiabilities
0
CY2020Q3 us-gaap Loans Receivable Fair Value Disclosure
LoansReceivableFairValueDisclosure
4562000
CY2020Q3 us-gaap Other Real Estate
OtherRealEstate
1623000
CY2019Q4 us-gaap Loans Receivable Fair Value Disclosure
LoansReceivableFairValueDisclosure
4001000
CY2019Q4 us-gaap Other Real Estate
OtherRealEstate
1623000
bcbp Lessee Operating Leases Number
LesseeOperatingLeasesNumber
28
CY2020Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
850000
CY2019Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
812000
us-gaap Operating Lease Cost
OperatingLeaseCost
2559000
us-gaap Operating Lease Cost
OperatingLeaseCost
2374000
CY2020Q3 us-gaap Variable Lease Cost
VariableLeaseCost
201000
CY2019Q3 us-gaap Variable Lease Cost
VariableLeaseCost
132000
us-gaap Variable Lease Cost
VariableLeaseCost
599000
us-gaap Variable Lease Cost
VariableLeaseCost
440000
CY2020Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
15798000
CY2019Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
13246000
CY2020Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3054000
CY2019Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2590000
CY2020Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
12950000
CY2019Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
10790000
CY2020Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
16004000
CY2019Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
13380000
CY2020Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y8M4D
CY2019Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y8M8D
CY2020Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0267
CY2019Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0316
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
3054000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
2590000
CY2020Q3 bcbp Lessee Operating Lease Liability Payments Year One To Year Three
LesseeOperatingLeaseLiabilityPaymentsYearOneToYearThree
5131000
CY2019Q4 bcbp Lessee Operating Lease Liability Payments Year One To Year Three
LesseeOperatingLeaseLiabilityPaymentsYearOneToYearThree
4713000
CY2020Q3 bcbp Lessee Operating Lease Liability Payments Year Three To Year Five
LesseeOperatingLeaseLiabilityPaymentsYearThreeToYearFive
3341000
CY2019Q4 bcbp Lessee Operating Lease Liability Payments Year Three To Year Five
LesseeOperatingLeaseLiabilityPaymentsYearThreeToYearFive
2736000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
4478000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
3341000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
16004000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
13380000

Files In Submission

Name View Source Status
0001228454-20-000012-index-headers.html Edgar Link pending
0001228454-20-000012-index.html Edgar Link pending
0001228454-20-000012.txt Edgar Link pending
0001228454-20-000012-xbrl.zip Edgar Link pending
bcbp-20200930.xsd Edgar Link pending
bcbp-20200930x10q.htm Edgar Link pending
bcbp-20200930x10q_htm.xml Edgar Link completed
bcbp-20200930xex31_1.htm Edgar Link pending
bcbp-20200930xex31_2.htm Edgar Link pending
bcbp-20200930xex32.htm Edgar Link pending
bcbp-20200930_cal.xml Edgar Link unprocessable
bcbp-20200930_def.xml Edgar Link unprocessable
bcbp-20200930_lab.xml Edgar Link unprocessable
bcbp-20200930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending